• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: STAAR SURGICAL COMPANY IMPLANTABLE COLLAMER LENS (ICL); PHAKIC TORIC INTRAOCULAR LENS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

STAAR SURGICAL COMPANY IMPLANTABLE COLLAMER LENS (ICL); PHAKIC TORIC INTRAOCULAR LENS Back to Search Results
Model Number VTICMO13.2
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Endophthalmitis (1835); Loss of Vision (2139); Vitrectomy (2643); No Code Available (3191)
Event Date 07/13/2020
Event Type  Injury  
Manufacturer Narrative
This product is not marketed in the us.(b)(4).Work order search: no similar complaint type events were reported for units within the same lot.Device history record (dhr) review: based on the results of the investigation, all released devices from the associated work order (s), including the suspected device, have been manufactured within established process parameters; and there is no indication that the manufacturing and processing of the device contribute to the complaint issue.
 
Event Description
The reporter indicated that a 13.2mm, vticmo13.2 implantable collamer lens, -16.50/1.50/165 (sphere/cylinder/axis) was implanted into the patients right eye (od) on (b)(6) 2020.Endophthalmitis and loss of vision were observed.Diagnostics (prp of vitreous sample) and medical intervention (vitreous biopsy, core vitrectomy, intravitreal vancomycin, intavitreal piperacillin tazobactam) were performed.Vitreous biopsy sample revealed pseudomonas aeruginosa.On (b)(6) 2020 the lens was explanted and additional intervention/treatment was performed (anterior chamber wash, vitreous biopsy, vitrectomy, fluid- air exchange, silicone oil injection, intravitreal vancomycin, intravitreal piperacillin tazobactam, intravitreal dexamethsone).Vitreous biopsy was sent for repeat grams stain, koh mount, culture and sensitivity for bacteria and fungus.On (b)(6) 2020 vitreous culture showed no growth.Additional information has been requested but none has been forthcoming.If additional information is received a supplemental medwatch report will be submitted.
 
Manufacturer Narrative
Information received on 21 sep 2020: patient had no general health conditions.Patient was prepped with povidone iodine.A prophylactic intracameral (moxifloxacin) antibiotic was used at the time of implantaion.Patient has pl+ve vision in the affected eye.Visual prognosis is not good.Claim # (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
IMPLANTABLE COLLAMER LENS (ICL)
Type of Device
PHAKIC TORIC INTRAOCULAR LENS
Manufacturer (Section D)
STAAR SURGICAL COMPANY
1911 walker avenue
monrovia, ca
MDR Report Key10463780
MDR Text Key204753358
Report Number2023826-2020-01914
Device Sequence Number1
Product Code QCB
Combination Product (y/n)N
PMA/PMN Number
NA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type distributor,foreign,health pr
Type of Report Initial,Followup
Report Date 07/29/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date07/31/2022
Device Model NumberVTICMO13.2
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 07/29/2020
Initial Date FDA Received08/27/2020
Supplement Dates Manufacturer Received09/21/2020
Supplement Dates FDA Received10/21/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
CARTRIDGE MODEL: SFC-45 W/FTP, LOT# UNK; INJECTOR MODEL: MSI-PF, LOT# UNK; CARTRIDGE MODEL: SFC-45 W/FTP, LOT# UNK; INJECTOR MODEL: MSI-PF, LOT# UNK
Patient Outcome(s) Required Intervention;
Patient Age39 YR
-
-